Dual antiplatelet therapy reduces major ischemic events in week 1 of minor stroke or TIA
Dual antiplatelet therapy reduces stroke risk in first week
This meta-analysis of 27,167 patients with minor ischemic stroke or high-risk TIA found that DAPT significantly reduced major ischemic event…
A new analysis shows dual antiplatelet therapy significantly lowers stroke risk in the first week, but carries a higher risk of bleeding.
Dual antiplatelet therapy reduces all-cause death but not MACE or myocardial infarction in MINOCA
Dual antiplatelet therapy shows survival benefits for MINOCA patients
This meta-analysis of 13027 patients with myocardial infarction with nonobstructive coronary artery disease (MINOCA) found that dual antipla…
New data suggests that dual antiplatelet therapy may help reduce the risk of death in patients with a specific type of heart attack.
Early DAPT associated with higher excellent functional outcome in minor stroke patients with history of DM
Early dual antiplatelet therapy may help stroke patients with diabetes
This secondary analysis of 995 Chinese patients with minor stroke and intravenous thrombolysis found that early dual antiplatelet therapy (D…
New data suggests early dual antiplatelet therapy could lead to better recovery for Chinese patients with a history of diabetes after a mino…
Tirofiban plus aspirin associated with lower early neurological deterioration in branch atheromatous disease
Early tirofiban plus aspirin linked to fewer early neurological declines in branch atheromatous disease patients
A retrospective single-center cohort study in patients with acute branch atheromatous disease found early tirofiban plus aspirin was associa…
Early tirofiban plus aspirin reduced early neurological decline from 55.1% to 10.1% in branch atheromatous disease patients compared to stan…